All of DSpace

Show simple item record

HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT

dc.creatorGoulis, L.en
dc.creatorAkriviadis, E.en
dc.creatorKaratapanis, S.en
dc.creatorDeutsch, M.en
dc.creatorDalekos, G. N.en
dc.creatorRaptopoulou-Gigi, M. P.en
dc.creatorDrakoulis, C.en
dc.creatorMimidis, K.en
dc.creatorGermanidis, G.en
dc.creatorNikolopoulou, V.en
dc.creatorChounta, A.en
dc.creatorBakalos, G.en
dc.creatorPapatheodoridis, G. V.en
dc.date.accessioned2015-11-23T10:28:51Z
dc.date.available2015-11-23T10:28:51Z
dc.date.issued2011
dc.identifier.issn0270-9139
dc.identifier.urihttp://hdl.handle.net/11615/28109
dc.source.uri<Go to ISI>://WOS:000295578003614
dc.subjectGastroenterology & Hepatologyen
dc.titleHBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORTen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record